Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
To investigate the possible role of dopamine, a catecholamine with natriuretic properties, in modulating the escape from the sodium-retaining effects of mineralocorticoids, we submitted six aldosterone-producing adenoma (APA) patients and six low-renin essential hypertensive patients to acute volume expansion by head-out water immersion with or without dopaminergic blockade by metoclopramide. Water immersion alone induced a marked, comparable natriuresis (P < 0.001) in both hypertensive groups where a slight reduction of already suppressed renin-angiotensin system and a marked stimulation of atrial natriuretic peptide was also observed (P < 0.03 and P < 0.002, respectively). Water immersion plus dopaminergic blockade by metoclopramide did not significantly affect the natriuresis observed during water immersion alone in APA patients; conversely, there was a blunted natriuretic response in low-renin hypertensives during water immersion plus metoclopramide, in comparison with that obtained during water immersion alone (P < 0.006). Furthermore, metoclopramide did prevent the suppression of plasma aldosterone levels produced by central volume expansion alone in low-renin hypertensives, although it did not affect plasma aldosterone levels during water immersion in APA patients. Our data suggest that dopaminergic blockade does not counteract the natriuretic ability of the other hemodynamic and humoral mechanisms involved in the escape phenomenon of APA patients, thus casting serious doubt on the possible role of dopamine in mediating the escape from the sodium-retaining effects of mineralocorticoids.
Coruzzi
P
P
Institute of Semeiotica Medica, University of Parma, Italy.
D000236:Adenoma / Q000378:metabolism / Q000503:physiopathology; D000328:Adult; D000450:Aldosterone / Q000097:blood / Q000378:metabolism; D009320:Atrial Natriuretic Factor / Q000097:blood; D001794:Blood Pressure / Q000502:physiology; D003404:Creatinine / Q000652:urine; D004298:Dopamine / Q000502:physiology*; D005260:Female; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D006929:Hyperaldosteronism / Q000097:blood / Q000503:physiopathology / Q000652:urine; D006973:Hypertension / Q000097:blood / Q000503:physiopathology / Q000652:urine; D007101:Immersion; D007552:Isotonic Solutions; D007668:Kidney / Q000502:physiology; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology; D008875:Middle Aged; D008901:Mineralocorticoids / Q000494:pharmacology*; D011188:Potassium / Q000652:urine; D012083:Renin / Q000097:blood; D012084:Renin-Angiotensin System / Q000502:physiology; D012964:Sodium / Q000378:metabolism* / Q000652:urine; D012965:Sodium Chloride; D014554:Urination / Q000502:physiology
D007552:Isotonic Solutions; D008901:Mineralocorticoids; D012965:Sodium Chloride; D000450:Aldosterone; D009320:Atrial Natriuretic Factor; D012964:Sodium; D003404:Creatinine; D012083:Renin; D008787:Metoclopramide; D011188:Potassium; D004298:Dopamine